Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (71-80 of 365) with videos related to

Pageof 37
Sort By:
Scientific American|October 13, 1998
Designer estrogensV C Jordan
Progress in Clinical and Biological Research|January 1, 1988
Long-term tamoxifen therapy to control or to prevent breast cancer: laboratory concept to clinical trialsV C Jordan
European Journal of Cancer & Clinical Oncology|August 1, 1988
The control of hormone-dependent breast cancer growth--are we talking about estrogen alone?V C Jordan
Hospital Practice (1995)|September 29, 1998
Preventing breast cancer with tamoxifenV C Jordan
Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1993
Molecular mechanisms of resistance to tamoxifen therapy in breast cancerM Morrow, V C Jordan
Molecular and Cellular Endocrinology|September 1, 1977
Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysisV C Jordan, G Prestwich
Endocrinology|August 1, 1983
Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018V C Jordan, B Gosden
Advances in Surgery|September 21, 2000
Tamoxifen to prevent breast cancerM Morrow, V C Jordan
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell lossA Friedl, V C Jordan
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Should clinicians be concerned about the carcinogenic potential of tamoxifen?V C Jordan, M Morrow
Pageof 37

Showing results (71-80 of 365) with videos related to

Sort By:
Pageof 37
Scientific American|October 13, 1998
Designer estrogensV C Jordan
Progress in Clinical and Biological Research|January 1, 1988
Long-term tamoxifen therapy to control or to prevent breast cancer: laboratory concept to clinical trialsV C Jordan
European Journal of Cancer & Clinical Oncology|August 1, 1988
The control of hormone-dependent breast cancer growth--are we talking about estrogen alone?V C Jordan
Hospital Practice (1995)|September 29, 1998
Preventing breast cancer with tamoxifenV C Jordan
Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1993
Molecular mechanisms of resistance to tamoxifen therapy in breast cancerM Morrow, V C Jordan
Molecular and Cellular Endocrinology|September 1, 1977
Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysisV C Jordan, G Prestwich
Endocrinology|August 1, 1983
Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018V C Jordan, B Gosden
Advances in Surgery|September 21, 2000
Tamoxifen to prevent breast cancerM Morrow, V C Jordan
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell lossA Friedl, V C Jordan
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Should clinicians be concerned about the carcinogenic potential of tamoxifen?V C Jordan, M Morrow
Pageof 37